ECAT: Saba Capital sells 9,750 shares, holds 26.85M indirectly
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares.
Rhea-AI Filing Summary
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On 11/19/2025, Saba disposed of 9,750 shares of ECAT common stock in an open-market sale at a price of $15.64 per share. After this transaction, Saba reported beneficial ownership of 26,853,335 ECAT shares, held indirectly. This filing is a routine disclosure of insider trading activity required for large shareholders.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 9,750 | $15.64 | $152K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Saba Capital Management report in this ECAT Form 4 filing?
Saba Capital Management, L.P. reported that it sold 9,750 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock in a transaction dated 11/19/2025.
What is Saba Capital Management’s relationship to BlackRock ESG Capital Allocation Term Trust (ECAT)?
In this filing, Saba Capital Management, L.P. is identified as a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT).
Does this ECAT Form 4 filing involve derivative securities?
The section for derivative securities in this filing, labeled Table II, does not list any derivative securities acquired, disposed of, or beneficially owned in the reported transaction.
Who signed the Form 4 for Saba Capital Management regarding ECAT?
The Form 4 was signed on behalf of Saba Capital Management, L.P. by Zachary Gindes, and by Boaz Weinstein as a reporting person, each with a signature date of 11/20/2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.